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Abstract
Post-translational modifications such as ubiquitination are important for orchestrating the
cellular transformations that occur as the Leishmania parasite differentiates between its
main morphological forms, the promastigote and amastigote. 2 E1 ubiquitin-activating (E1),
13 E2 ubiquitin-conjugating (E2), 79 E3 ubiquitin ligase (E3) and 20 deubiquitinating cyste-
ine peptidase (DUB) genes can be identified in the Leishmania mexicana genome but, cur-
rently, little is known about the role of E1, E2 and E3 enzymes in this parasite. Bar-seq
analysis of 23 E1, E2 and HECT/RBR E3 null mutants generated in promastigotes using
CRISPR-Cas9 revealed numerous loss-of-fitness phenotypes in promastigote to amasti-
gote differentiation and mammalian infection. The E2s UBC1/CDC34, UBC2 and UEV1 and
the HECT E3 ligase HECT2 are required for the successful transformation from promasti-
gote to amastigote and UBA1b, UBC9, UBC14, HECT7 and HECT11 are required for nor-
mal proliferation during mouse infection. Of all ubiquitination enzyme null mutants examined
in the screen, Δubc2 and Δuev1 exhibited the most extreme loss-of-fitness during differenti-
ation. Null mutants could not be generated for the E1 UBA1a or the E2s UBC3, UBC7,
UBC12 and UBC13, suggesting these genes are essential in promastigotes. X-ray crystal
structure analysis of UBC2 and UEV1, orthologues of human UBE2N and UBE2V1/
UBE2V2 respectively, reveal a heterodimer with a highly conserved structure and interface.
Furthermore, recombinant L.mexicana UBA1a can load ubiquitin onto UBC2, allowing
UBC2-UEV1 to form K63-linked di-ubiquitin chains in vitro. Notably, UBC2 can cooperate in
vitro with human E3s RNF8 and BIRC2 to form non-K63-linked polyubiquitin chains, show-
ing that UBC2 can facilitate ubiquitination independent of UEV1, but association of UBC2
with UEV1 inhibits this ability. Our study demonstrates the dual essentiality of UBC2 and
UEV1 in the differentiation and intracellular survival of L.mexicana and shows that the inter-
action between these two proteins is crucial for regulation of their ubiquitination activity and
function.
PLOS PATHOGENS
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Author summary
The post-translational modification of proteins is key for allowing Leishmania parasites
to transition between the different life cycle stages that exist in its insect vector and mam-
malian host. In particular, components of the ubiquitin system are important for the
transformation of Leishmania from its insect (promastigote) to mammalian (amastigote)
stage and normal infection in mice. However, little is known about the role of the
enzymes that generate ubiquitin modifications in Leishmania. Here we characterise 28
enzymes of the ubiquitination pathway and show that many are required for life cycle
progression or mouse infection by this parasite. Two proteins, UBC2 and UEV1, were
selected for further study based on their importance in the promastigote to amastigote
transition. We demonstrate that UBC2 and UEV1 form a heterodimer capable of carrying
out ubiquitination and that the structural basis for this activity is conserved between
Leishmania, Saccharomyces cerevisiae and humans. We also show that the interaction of
UBC2 with UEV1 alters the nature of the ubiquitination activity performed by UBC2.
Overall, we demonstrate the important role that ubiquitination enzymes play in the life
cycle and infection process of Leishmania and explore the biochemistry underlying UBC2
and UEV1 function.
Introduction
Leishmaniasis is a neglected tropical disease caused by parasites of the genus Leishmania. This
disease, which has a tropical and sub-tropical distribution, is transmitted by the bite of a sand-
fly and causes around 70,000 deaths annually [1]. During their complex, digenetic life cycle,
Leishmania differentiate between two main morphological forms: the motile, extracellular pro-
mastigote form in the sand fly vector and the non-motile, intracellular amastigote form in the
mammalian host. Of the numerous promastigote forms that exist in the sandfly, procyclic pro-
mastigotes are the most actively dividing and metacyclic promastigotes are the transmissible
form [2]. In order for Leishmania cells to transition between the disparate environments of the
sandfly mouthparts and mammalian phagolysosomes, substantial changes in gene expression,
particularly at the post-transcriptional level, are required [3, 4]. The post-translational modifi-
cations phosphorylation and ubiquitination, for example, are thought to contribute signifi-
cantly to the differentiation process [5–8].
Ubiquitination regulates numerous cellular processes including proteasomal degradation,
endocytic trafficking and DNA repair [9]. Addition of the 8.5 kDa protein ubiquitin (Ub) to
proteins is carried out by the sequential actions of E1 ubiquitin-activating (E1), E2 ubiquitin-
conjugating (E2) and E3 ubiquitin ligase (E3) enzymes. Typically, an E1 activates ubiquitin in
an ATP-dependent manner by adenylating its C-terminus, allowing a thioester bond to form
between the E1 active site and ubiquitin. Subsequently, ubiquitin is transferred to the active
site of an E2 via trans-thioesterification and then onto the substrate with the help of an E3
ligase. Most commonly, ubiquitination occurs on a lysine residue, although modification of
cysteine, serine, threonine and the N-termini of proteins are also possible [10]. E3 ligases can
be grouped into two categories based on their mechanism of action. Cys-dependent E3s such
as the HECT (Homologous to the E6-AP Carboxyl Terminus) and RBR (Ring-Between-Ring)
E3s contain a cysteine residue that forms a thioester bond with ubiquitin prior to transfer to
the substrate. Conversely, Cys-independent E3s such as the RING (really interesting new
gene) and U-box E3s facilitate the direct transfer of ubiquitin between E2 and substrate by
PLOS PATHOGENS E2 ubiquitin-conjugation complex of Leishmania
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008784 October 27, 2020 2 / 30
analysis, decision to publish, or preparation of the
manuscript.
Competing interests: The authors have declared
that no competing interests exist.
providing a scaffold that orients the ubiquitin-charged E2 relative to the substrate [11]. Ubi-
quitin-like modifiers (Ubls) such as SUMO and Nedd8 have a similar, but distinct, E1-E2-E3
conjugation pathway to that of ubiquitin [12]. The removal of ubiquitin modifications is car-
ried out by deubiquitinating enzymes (DUBs) [9].
A huge diversity of ubiquitin modifications exists, due in part to the ability of ubiquitin
itself to be ubiquitinated on any of the epsilon amino groups of its 7 lysine side chains or on
the alpha amino group of its N-terminus. This allows for the formation of linear or branched
polyubiquitin chains. Acetylation, phosphorylation and the modification of ubiquitin with
other Ubls (including SUMO and Nedd8) are also possible [13]. The huge array of potential
modifications permits a range of signalling outcomes. For example, K48-linked chains, the
most common ubiquitin chain type, target proteins for proteasomal degradation. In contrast,
K63-linked chains typically provide a non-degradative signal, for example in promoting the
recruitment of proteins to sites of DNA damage [9].
To date, two ubiquitin-activating enzymes have been described in Leishmania major [14],
and at least 20 cysteine peptidase DUBs exist in Leishmania mexicana, many of which are
essential for the promastigote to amastigote transition [8]. The importance of the ubiquitina-
tion system in these species is further exemplified by the finding that the Leishmania protea-
some is essential for parasite survival, since many forms of ubiquitin modification target
proteins for proteasomal degradation [15, 16]. The L.major Atg8 and Atg12 Ubls have been
shown to play a role in parasite autophagy [17, 18] and, although they have yet to be properly
described in Leishmania, SUMO- and Nedd8-conjugation systems exist in the closely-related
kinetoplastid Trypanosoma brucei [19–24]. The Ubls Ufm1 and Urm1 also exist in Leishmania
[25–27]. However, little is currently known about the role that ubiquitin E1, E2 and E3
enzymes play in Leishmania biology. In this study we characterise the E1, E2 and E3 enzymes
of L.mexicana by analysing the fitness of an E1, E2 and HECT/RBR E3 null mutant library
throughout the Leishmania life cycle. We show that, amongst others, the E2 ubiquitin-conju-
gating enzyme UBC2 and the ubiquitin E2 variant UEV1 are essential for the promastigote to
amastigote transition and subsequently characterise these proteins in biochemical and struc-
tural detail.
Results
Ubiquitination gene families in L.mexicana
Initial analysis of the L.mexicana genome using Interpro and PFAM domain searches identi-
fied 4 E1 ubiquitin-activating (UBA), 15 E2 ubiquitin-conjugating (UBC) and 81 E3 ligase
genes (S1 Table). The putative E3s included 14 HECT, 1 RBR, 57 RING, 4 RING-CH-type and
5 U-box E3s. Upon more detailed analysis, however, LmxM.08.0220 and LmxM.02.0390 were
found to be orthologues of T. bruceiUba2 and Ubc9, which have been identified as an E1 cata-
lytic subunit and E2 enzyme for the Ubl SUMO respectively and were named UBA2 and
UBC9 based on this orthology [22]. Similarly, LmxM.01.0710 (UBA3) was found to share
more similarity with HsUBA3 (68% query cover, 35.8% identity, E value: 8e-64), a Nedd8-acti-
vating enzyme catalytic subunit, than the ubiquitin E1 HsUBA1 (46% query cover, 31.7% iden-
tity, E value: 3e-25) and LmxM.24.1710 (UBC12) appears to be an orthologue of T. brucei
Ubc12, an E2 Nedd8-conjugating enzyme [24]. For two of the HECT domain-containing
genes,HECT13 andHECT14, only partial HECT domains of 69 and 60 amino acids were iden-
tified respectively, suggesting that they do not function as E3s. Following the removal of Ubl
E1 and E2s and possible pseudo-HECTs from the list of identified ubiquitination genes, 2 ubi-
quitin E1s, 13 ubiquitin E2s and 79 E3 ligase genes were proposed to be present in the L.mexi-
cana genome. Of these, UBC1, a ubiquitin E2, is related to T. brucei CDC34 (99% query cover,
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55.2% identity, E value: 2e-105), required for cytokinesis and infection progression of blood-
stream form parasites in mice [28]. UBC4, also a ubiquitin E2, is related to T. brucei PEX4
(100% query cover, 58.6% identity, E value: 5e-72), implicated in the ubiquitination of TbPEX5,
a cytosolic receptor involved in peroxisome biogenesis [29].
Of the putative ubiquitination genes identified, the predicted molecular weights of
encoded proteins range from between 115–127 kDa for E1s, 16–49 kDa for E2s, 147–733
kDa for HECT E3 ligases and 9–288 kDa for RING, RING-CH-type and U-box E3 ligases.
Only one RBR-type E3 ligase, with a predicted molecular weight of 58 kDa, was identified.
An alignment of UBA1a and UBA1b with human ubiquitin E1s (S1A Fig) revealed conser-
vation of the catalytic cysteine residue (C596 in UBA1a and C651 in UBA1b, equivalent to
C632 in HsUBA1). Similarly, an alignment of L.mexicana and human E2s showed conser-
vation of the conserved catalytic cysteine in all L.mexicana E2s except UEV1 (S1B Fig), sug-
gesting the latter is a non-catalytic ubiquitin E2 variant [30]. Furthermore, the HPN (His-
Pro-Asn) motif, which is conserved in human E2s and which contains an asparagine residue
that can be important for catalysis [31–33], was found to be partially or completely missing
in UBC3, UBC6, UBC11, UBC14 and UEV1. A HECT domain alignment for L.mexicana
HECT E3 ligases and 4 human HECT E3 ligases showed that HECTs 1–12 contained the
conserved catalytic cysteine residue. Consistent with the identification of a partial HECT
domain in HECT13 and HECT14, a putative catalytic cysteine was absent in these sequences
(S1C Fig).
A bar-seq screen reveals the importance of ubiquitination genes in the L.
mexicana life cycle
In order to investigate the role of ubiquitination, SUMOylation and Neddylation genes in the
life cycle of L.mexicana, the 4 E1, 15 E2 and HECT and RBR subgroups of E3 genes (12 and 1
gene respectively) from our bioinformatics analysis were targeted for deletion in procyclic pro-
mastigotes using CRISPR-Cas9 [34]. The repair cassettes used for integration into the targeted
gene locus contained unique, 12 nucleotide barcodes to allow for the identification of individ-
ual null mutant lines in a pooled library and drug resistance markers. Details of the primers
and plasmids used are provided in S2 Table. Null mutant lines were validated using PCRs to
detect removal of the gene of interest and integration of the blasticidin repair cassette (S2A Fig
and S2B Fig) and, where a null mutant was not immediately generated, three rounds of trans-
fection were performed to reduce the likelihood of not obtaining a null mutant line due to
technical failure. A similar strategy was used for the generation of a Δhect12mutant but will be
described elsewhere. In this way, null mutants were generated for all genes except UBA1a,
UBC3, UBC7, UBC12 and UBC13, suggesting that 1 out of 2 ubiquitin E1s and 4 out of 13 ubi-
quitin E2s may be essential in promastigotes. Although drug resistant clones were obtained for
UBA1a, UBC3, UBC7 and UBC12, they still contained the gene of interest (S2C Fig). This
lends further support to the proposition that UBA1a, UBC3, UBC7 and UBC12 are essential in
promastigotes, since it suggests that gene duplication events have occurred to allow the para-
site to retain the gene. Notably, a null mutant was successfully generated for the Nedd8 E1
UBA3 despite UBC12 (Nedd8 E2) appearing to be essential. This suggests that the essential
role of UBC12 may be independent of UBA3. None of the SUMOylation, HECT E3 or RBR E3
genes were essential in promastigotes, as evidenced by the successful generation of null
mutants for these genes.
Next, barcode analysis by sequencing (bar-seq), which involves the parallel phenotyping of
a null mutant pool using next-generation sequencing, was used to analyse the null mutants
[35]. Briefly, 58 promastigote-stage null mutants including the 3 E1, 10 E2 (excluding Δubc5)
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and 13 HECT/RBR E3 null mutants alongside 16 DUB, 13 other peptidase and 4 protein kinase
null mutants were pooled in equal proportions and in 6 replicate samples. Pooled promastigote
(PRO) cultures were grown for 7 days and then induced to form axenic amastigotes (AXA) or
used to purify metacyclic stage promastigotes (META). Purified metacyclic cells were used to
infect macrophages (inMAC) in culture or mice using footpad injection (FP). At the time
points indicated in Fig 1A, DNA was extracted to allow for amplification of the barcoded
regions by PCR and quantitative analysis by next generation sequencing; the raw data are
Fig 1. Life cycle phenotyping of ubiquitination gene null mutants. Fifty-eight null mutant lines were pooled (n = 6) as procyclic promastigotes and grown to
stationary phase. Cells were then induced to differentiate into axenic amastigotes in vitro or metacyclic promastigotes purified and used to infect macrophages
or mice.A Experimental workflow showing the time points at which DNAwas extracted for barcode amplification and next generation sequencing. The heat
maps for promastigote to B axenic amastigote, Cmacrophage infection orDmouse infection experiments show the average proportional representation of
each null mutant at each experimental time point, calculated by dividing the number of reads for null mutant-specific barcodes by the total number of reads for
expected barcodes. Samples included represent promastigote time-point zero (PRO 0 h), early-log phase (PRO 24 h), mid-log phase (PRO 48 h), late-log phase
(PRO 72 h), stationary phase (PRO 168 h), early axenic amastigote differentiation (AXA 24 h), post-axenic amastigote differentiation (AXA 120 h), purified
metacyclic promastigotes (META), early macrophage infection (inMAC 12 h), late macrophage infection (inMAC 72 h), 3 week footpad mouse infection (FP 3)
and 6 week footpad mouse infection (FP 6).
https://doi.org/10.1371/journal.ppat.1008784.g001
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available in S4 Table in Damianou et al., 2020 [8]. The heat maps in Fig 1B–1D show the propor-
tional representation of each null mutant line at each experimental time point, with a gradient of
white to red representing proportions ranging between zero and 0.04 (or above) respectively. Pro-
portional representation was calculated by dividing the number of reads for an individual barcode
by the total number of reads for all expected barcodes and averaging over the 6 replicates. Loss-of-
fitness phenotypes were inferred from decreases in proportional representation from one time
point to the next. For Δuba2, only 2.6 x 106, instead of 4 x 106 cells, were added to the pools due to
the poor prior growth of this cell line. Furthermore, the associated barcode was not detected in all
of the PRO 0 h time points, perhaps due to the lower representation of Δuba2 in the pool, prompt-
ing the decision to exclude this cell line from the analysis.
Between the PRO 0 h and PRO 168 h samples, there was no complete loss of any null
mutant line from the populations, although several significant loss-of-fitness phenotypes
(decreases in proportional representation within the population) were observed between adja-
cent timepoints (<0.05, paired t-test, Holm-Šı́dák method, S4 Table, Damianou et al., 2020
[8]). For example, reduced fitness was seen at two or more promastigote time points for
Δubc9, Δhect2 and Δhect12. No loss-of-fitness phenotypes were observed between the PRO 168
h and META samples or between the PRO 168 h and AXA 24 h samples.
Within both the AXA 24 h-AXA 120 h and META-inMAC 12 h intervals, loss-of-fitness
was observed for 10 null mutants: Δuba1b, Δubc2, Δubc6, Δubc8, Δubc9, Δuev1, Δhect2, Δhect4,
Δhect7 and Δrbr1, demonstrating good correlation between these two experiments. Of these,
strong defects (>3-fold decrease in fitness between both intervals) were observed for Δubc1/
cdc34, Δubc2, Δuev1 and Δhect2. In addition, Δubc4/pex4, Δubc11, Δubc14, Δhect5, Δhect6,
Δhect11 and Δhect12 showed loss-of-fitness between the AXA 24 h and AXA 120 h samples
and Δhect10 showed a reduction in fitness between the META and inMAC 12 h samples. Fur-
ther loss-of-fitness for Δubc8 and Δrbr1 was observed between inMAC 12 h and inMAC 72 h.
All null mutant lines that showed loss-of-fitness defects in the axenic amastigote and macro-
phage samples also had compromised fitness in the mouse, although many of the phenotypes
observed were more severe. Specifically, Δuba1b, Δubc1/cdc34, Δubc2, Δubc9, Δubc14, Δuev1,
Δhect2, Δhect7 and Δhect11 had at least 20-fold reductions in fitness between the META and
FP 3 samples. Additionally, Δuba3 and Δhect1 showed small decreases in fitness during this
interval. Notably, Δubc1/cdc34, Δubc2, Δuev1 and Δhect2 showed the most dramatic and con-
sistent loss-of-fitness phenotypes, including>5-fold,>25-fold and>200-fold decreases in fit-
ness across the axenic amastigote, macrophage infection and mouse infection experiments
respectively (calculated between the PRO 168 h/META sample and the experimental end-
points). A pBLAST search revealed that HECT2 is related to human UBE3C (28% query cover,
35.3% identity, 1e-64 E value), a HECT E3 ligase that ubiquitinates proteasome substrates to
enhance proteasomal processivity [36]. Overall, Δubc2 and Δuev1 had the most severe pheno-
types with reductions in fitness of 50-fold in the axenic amastigote, 300-fold in the macrophage
and a complete loss-of-fitness (to zero) in the mouse. The strong defects observed for Δubc1/
cdc34, Δubc2, Δuev1 and Δhect2 in pooled axenic amastigote differentiation were also observed
individually using a cell viability assay (S2D Fig, S3 Table).
UBC2 and UEV1 are orthologues of human UBE2N and UBE2V1/UBE2V2
Since Δubc2 and Δuev1 showed the most severe loss-of-fitness phenotypes in the bar-seq
screen, we decided to investigate their function. The most probable orthologues of L.mexicana
UBC2 (LmxM.04.0680) and UEV1 (LmxM.13.1580) were identified in the Trypanosoma bru-
cei, Saccharomyces cerevisiae and human genomes using protein BLAST searches and the two
groups of sequences aligned. Fig 2A shows that there is a high level of conservation between
PLOS PATHOGENS E2 ubiquitin-conjugation complex of Leishmania
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Fig 2. Alignments of LmUBC2 and LmUEV1 with selected orthologues. Sequence alignment and structural annotation were performed
using T-Coffee and ESPript 3.0 respectively for A LmUBC2 and B LmUEV1. Red boxes indicate amino acid identity, red characters show
similarity within the highlighted group and blue frames highlight similarity across groups. Positions of the UBC2 HPNmotif and catalytic
cysteine are shown by a black line and triangle respectively. Secondary structures derived from the crystallised L.mexicanaUBC2-UEV1
heterodimer (Fig 4) are represented above the sequence alignment with helices represented by spirals and beta sheets by arrows. Asterisks
denote important interface residues in the L.mexicana complex. Lm, Leishmania mexicana; Tb, Trypanosoma brucei; Sc, Saccharomyces
cerevisiae; Hs,Homo sapiens.
https://doi.org/10.1371/journal.ppat.1008784.g002
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UBC2 and its predicted orthologues. Specifically, UBC2 shares 77%, 66% and 70% amino acid
identity with the equivalent T. brucei, S. cerevisiae and human proteins respectively. Such a
high level of shared identity suggests that UBC2 functions are likely to be well-conserved. In
contrast, UEV1 is less well conserved with its orthologues, sharing 70%, 54% and 47% amino
acid identity with the equivalent T. brucei, S. cerevisiae and human proteins respectively (Fig
2B). Consequently, there may be more functional divergence within this gene family. In
humans, UBE2N and UBE2V1/V2 form a heterodimeric complex specific for K63-linked ubi-
quitination and have been linked to inflammatory signalling [37] and DNA damage response
pathways [38].
UBC2 and UEV1 encode proteins of 148 and 138 amino acid residues respectively, corre-
sponding to predicted molecular weights of 17 kDa and 16 kDa. Based on the alignment in Fig
2A, the putative catalytic cysteine of UBC2 is C85, equivalent to C87 in S. cerevisiaeUBC13 and
C87 in human UBE2N [39]. UBC2 also contains an HPNmotif 10 amino acids N-terminal of
C85 that may be involved in catalysis [31–33]. All of the proteins in the UEV1 alignment (Fig
2B) lack catalytic cysteine residues and HPNmotifs, consistent with UEV1 being part of the
noncatalytic UEV family of E2s [30]. For the UEV1 alignment, isoform 3 (canonical sequence
in UniProtKB) of UBE2V1 was used as this is the most similar isoform to UEV1. However,
UBE2V1 is predicted to have numerous isoforms produced by alternative splicing. For example,
a 30 residue N-terminal extension of isoform 2 (UEV-1A) relative to UBE2V2 has previously
been shown to account for their differing functions [40]. Since UEV1 lacks such an N-terminal
extension, it could be predicted to be more similar in function to UBE2V2 than UBE2V1.
L.mexicanaUBC2 and UEV1 form a heterodimer
To permit biochemical characterisation of L.mexicanaUBC2 and UEV1, His-Im9-tagged [41]
UBC2 and UEV1 were expressed in Escherichia coli and purified following tag removal. In par-
allel, UBA1a, a putative ubiquitin E1 and the product of one of our proposed promastigote-
essential genes, was similarly expressed and purified. Two putative ubiquitin E1s exist in L.
mexicana, and, like T. bruceiUBA1a and UBA1b, are more closely related to human UBA1
than UBA6 [14]. Specifically, L.mexicanaUBA1a and UBA1b share 36% and 33% amino acid
identity with HsUBA1 respectively and 28% identity with each other. Based on its higher
shared identity with HsUBA1 and potential essentiality, it was reasoned that UBA1a would be
more likely to show a broad E2 specificity (comparable to that of HsUBA1) and therefore be
capable of loading ubiquitin onto UBC2 [42, 43]. All 3 proteins showed a good level of purity
as assessed by InstantBlue staining (Fig 3A). For UBC2 and UEV1 no additional proteins were
detected, whereas the UBA1a sample contained 2 extra proteins at around 74 and 100 kDa.
These appeared below UBA1a, suggesting the presence of co-purified protein or UBA1a degra-
dation products.
The orthologues of UBC2 and UEV1 in T. brucei, S. cerevisiae and humans have previously
been shown to form a heterodimeric complex [44–47]. To test whether this was also true in L.
mexicana, a size-exclusion chromatography multi-angle laser light scattering (SEC-MALLS)
approach was used. The chromatograms in Fig 3B show peaks in the refractive index repre-
senting the purified UBC2 and UEV1 samples at 25 and 26 min respectively. Measurement of
both the refractive index and multi-angle laser light scattering allowed an estimation of the
molecular weights of the recombinant proteins at 18.7 kDa and 18.2 kDa for UBC2 and UEV1
respectively (dashed lines above peaks in refractive index). These values are close to the pre-
dicted molecular weights of 17 kDa for UBC2 and 16 kDa for UEV1. That both of these pro-
teins eluted as a single peak is indicative of them existing in monomeric form while also
reflecting the high quality of the protein preparations. When UBC2 and UEV1 were mixed in
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an equimolar ratio, an elution peak was seen at 23 min, indicating the presence of a higher
molecular weight species (estimated at 34.2 kDa). Given that no peaks were seen representing
UBC2 and UEV1 monomers, it can be assumed that all protein material in this sample existed
in heterodimeric UBC2-UEV1 complexes. Therefore, L.mexicanaUBC2 and UEV1 readily
associate to form a heterodimeric UBC2-UEV1 complex.
Structure of the UBC2-UEV1 heterodimer
To investigate the conservation and interactions of UBC2 and UEV1 at the structural level, we
sought crystals of their complex. Crystals, which appeared after two days from polyethylene
glycol (PEG)-containing solutions, were sent for data collection at the Diamond Light Source,
with the best crystal yielding a dataset extending to 1.7 Å spacing. The structure was solved by
molecular replacement using the coordinates of the human UBE2N-UBE2V2 complex as the
search model (PDB ID: 1J7D) [48]. There are two UBC2-UEV1 heterodimers (PDB ID:
6ZM3) in the crystallographic asymmetric unit. These were found to have a similar structure
and subunit organisation following superposition of chains equivalent to UBC2, UEV1 or the
UBC2-UEV1 heterodimer by secondary structure matching (SSM) procedures, with RMSDs
of 0.32 Å, 0.74 Å and 1.13 Å for 146, 132 and 276 equivalent atoms respectively. Since residues
Gly20 to Asn24 are poorly defined in the electron density maps for one of the UEV1 chains,
the alternative UBC2-UEV1 heterodimer was the focus of our analysis.
Like its S. cerevisiae and human orthologues, UBC2 has a canonical E2 structure comprising
a 4-stranded antiparallel β-sheet flanked by four α-helices (Fig 4A). UEV1 exhibits a similar
topology, but its polypeptide chain is shorter and the prominent pair of α-helices at the C-ter-
minus of UBC2 (α3 and α4) are missing from UEV1. Relative to human UBE2V1 and
Fig 3. UBC2 and UEV1 form a stable heterodimer in vitro. A SDS-PAGE gel showing recombinant UBA1a, UBC2 and UEV1 stained with InstantBlue
stain. Proteins were expressed in E. coli and purified by nickel affinity and size-exclusion chromatography. 1 μg of each protein was loaded onto the gel. B
Elution profiles of UBC2, UEV1 and a 1:1 molar mix of UBC2-UEV1 presented as changes in refractive index over time. Curved lines show changes in
refractive index for UBC2-UEV1 (black), UBC2 (red) and UEV1 (blue). The expected mass (as estimated from light scattering data) in kDa is indicated by a
dashed line above the peak corresponding to each protein sample.
https://doi.org/10.1371/journal.ppat.1008784.g003
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UBE2V2, UEV1 has a shorter segment leading into the first α-helix (Fig 2B), a feature it shares
with S. cerevisiaeMms2. Superposing UBC2 with human UBE2N, UEV1 with human
UBE2V2 or the UBC2-UEV1 and UBE2N-UBE2V2 heterodimers (S3A Fig) gives RMSDs of
0.82, 1.15 and 1.13 Å for 147, 135 and 271 equivalent atoms respectively, demonstrating a high
level of structural conservation between these orthologues. The conserved active site residues,
His75, Pro76, Asn77 and Cys85, reside on an extended segment of the polypeptide that con-
nects strand β4 and helix α2 of UBC2, with the thiol group of Cys85 projecting out of the cata-
lytic cleft (Fig 4B). The high level of sequence conservation around these residues is reflected
in the close proximity of their superposed catalytic clefts.
Fig 4. Structure of the UBC2-UEV1 heterodimer. A Ribbon diagram showing the crystal structure of UBC2 (green) and UEV1 (blue) in complex. The location of
the N- and C-termini are highlighted along with the numbering of alpha helices (α) and beta strands (β). B Zoom-in of the conserved catalytic residues in UBC2.
The HPNmotif and proposed catalytic cysteine are shown as cylinders coloured by atom (red, oxygen; blue, nitrogen; yellow, sulfur). C-D Zoom-in of interface
between UBC2 and UEV1 with UBC2 or UEV1 as a surface fill model respectively. Amino acid residues are shown as cylinders coloured by atom (red, oxygen; blue,
nitrogen). Hydrogen bonds are denoted by dashed lines.
https://doi.org/10.1371/journal.ppat.1008784.g004
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The interface between UBC2 and UEV1 (Fig 4C and 4D, S3B Fig) involves the β2, β3 and
β4 strands and the loops following β1, β3 and β4 of UBC2 and the N-terminus, α1 helix and
loop following β1 of UEV1. The buried surface area of this interface is 1,466 Å2. The core of
the interface contains a number of hydrophobic residues (Tyr32, Phe55, Leu70 and Val81 of
UBC2 and Pro5, Phe8, Leu11, Leu14 and Phe39 of UEV1) that contribute strongly to the inter-
action. Hydrophobic residues are highly conserved at these positions (Fig 2), highlighting the
importance of the associated hydrophobic interactions for complex formation. These hydro-
phobic interactions are complemented by a number of polar intermolecular interactions,
mostly notably between the side chains of Glu53 of UBC2 and Asn7 of UEV1 and Arg68 of
UBC2 and the main chain carbonyl oxygen of Ile37 of UEV1. Both of these interactions are
conserved in the human complex although Met is present in place of Ile. Notably, a salt bridge
is formed between Arg83 of UBC2 and Glu18 of UEV1. Although these residues are conserved
in S. cerevisiae, human UBE2V1/2 has Gln in place of Glu. Asp38 and Glu39 residues in
human UBE2V2 provide hydrogen bonds for the interaction interface but are replaced by Thr
and Ala (at positions 34 and 35 respectively) in UEV1.
Ubiquitin transfer occurs between UBA1a and UBC2 in vitro
To assess whether UBA1a, UBC2 and UEV1 are an active E1, active E2 and inactive E2 variant
respectively, recombinant proteins were tested in thioester intermediate assays. Fig 5A shows
the results of incubating UBA1a, UBC2 and UEV1 in different combinations in the presence
of ubiquitin and ATP. In these assays, human ubiquitin, which has 2 amino acid substitutions
relative to L.mexicana ubiquitin (S4A Fig), was used. When UBA1a was present under non-
reducing conditions, the appearance of a UBA1a~Ub thioester intermediate (at around 125
kDa) was observed over time. Under reducing conditions, this intermediate was lost, confirm-
ing the presence of thioester-linked UBA1a~Ub. When UBA1a and UBC2 were combined
under non-reducing conditions, the appearance of an additional protein band at 26 kDa was
observed, suggesting the transfer of ubiquitin between UBA1a and UBC2 to form thioester-
linked UBC2~Ub. This protein complex was lost under reducing conditions, confirming its
identity as a UBC2~Ub thioester intermediate. In contrast, when UBA1a and UEV1 were com-
bined, no lower mobility species of UEV1 were observed, suggesting that UEV1 is unable
to receive ubiquitin from UBA1a. When UBA1a, UBC2 and UEV1 were combined, no
UBC2~Ub thioester intermediate was observed. It was reasoned that UEV1 could prevent
UBC2 from binding ubiquitin or, alternatively, that the presence of UEV1 facilitates the release
of ubiquitin from UBC2 or its transfer onto substrate(s) in solution. Conversely, the alternative
L.mexicana ubiquitin E1, UBA1b, was unable to transfer ubiquitin to UBC2, despite being
capable of forming thioester-linked UBA1b~Ub (S4B Fig). UBA1b was also unable to transfer
ubiquitin onto UEV1 (S4B Fig), showing that ubiquitin cannot be loaded onto UEV1 by either
of the two L.mexicana ubiquitin E1 enzymes. These results support the identities of UBA1a,
UBC2 and UEV1 as an active E1, active E2 and inactive E2 variant respectively.
UBC2 and UEV1 conjugate ubiquitin in vitro
Previous in vitro studies have demonstrated the ability of S. cerevisiaeUBC13 and MMS2 and
their human counterparts to promote the formation of ubiquitin chains in the absence of E3
enzyme [31, 40, 45, 46, 49]. To test whether the L.mexicana enzymes share this ability, differ-
ent combinations of UBC2 and UEV1 were incubated with UBA1a, ubiquitin and ATP and di-
ubiquitin formation monitored by immunoblotting for mono- and poly-ubiquitinated conju-
gates under reducing conditions. This approach was chosen in order to distinguish between
UBC2, UEV1 and di-ubiquitin, which all have similar molecular weights. Di-ubiquitin
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Fig 5. UBA1a and UBC2 cooperate in ubiquitin transfer in vitro. A Thioester assay demonstrating the ability of UBA1a and UBC2 to form thioester bonds
with ubiquitin. UBA1a, ubiquitin and ATP were incubated with UBC2 and UEV1 as indicated in ubiquitination assay buffer for up to 10 min at room
temperature. Samples were treated with either reducing or non-reducing sample buffer and visualised by SDS-PAGE with InstantBlue stain. BDi-ubiquitin
formation assay. UBA1a, ubiquitin and ATP were incubated with UBC2 and UEV1 as indicated in ubiquitination assay buffer for up to 90 min at 37˚C. Reactions
were then treated with reducing sample buffer and visualised by immunoblotting with either ubiquitin conjugate or K63-linked ubiquitin antibodies. CDi-
ubiquitin formation assay performed as for B but with wild-type ubiquitin substituted for K63R ubiquitin where shown.DUBC2 and UEV1 were pre-incubated
with UBE2N inhibitor NSC697923 as indicated for 15 min prior to setting up a di-ubiquitin formation assay as in B. For C andD, samples were treated with
reducing sample buffer prior to SDS-PAGE and immunoblotting with ubiquitin conjugate antibody. Data shown inA-D are representative. No 2/V1, no UBC2
or UEV1. E Schematic summarising the findings ofA-D. UBA1a activates ubiquitin in an ATP-dependent manner, allowing ubiquitin to bind to the active site of
UBA1a via a thioester linkage. Ubiquitin is then transferred to UBC2 (green) which, when present in complex with UEV1 (yellow), can generate free K63-linked
ubiquitin chains.
https://doi.org/10.1371/journal.ppat.1008784.g005
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formation was observed after 30 min in the presence of UBC2 and UEV1 and increased by 90
min (Fig 5B). In contrast, no di-ubiquitin formation was observed in the absence of either
UBC2 or UEV1, suggesting that both proteins are required for di-ubiquitin formation. An
additional protein that may represent tri-ubiquitin was observed above di-ubiquitin at the 90
minute time point, suggesting that higher order chains may be being assembled. Additionally,
since the reducing conditions would disrupt any UBC2-Ub thioester intermediates, the protein
at around 26 kDa in samples containing UBC2 may represent auto-ubiquitinated UBC2. Com-
parably, in vitro auto-ubiquitination of human UBE2N on K92, equivalent to K90 in UBC2,
has been observed [46]. Auto-ubiquitinated UBA1a also appears to be present at the top of the
blot.
Since S. cerevisiaeUBC13 and MMS2 and their human orthologues have been shown to
specifically form K63-linked ubiquitin chains [45, 46], the reactions described above were
additionally probed with a K63 linkage-specific antibody. The right-hand panel in Fig 5B
shows that K63-linked ubiquitin conjugates are formed by UBC2-UEV1. Furthermore, UBC2
and UEV1 were unable to conjugate K63R mutant ubiquitin, demonstrating the essential
requirement for K63 of ubiquitin in the formation of free ubiquitin chains by UBC2-UEV1
(Fig 5C). Pre-incubation of UBC2 with the covalent UBE2N inhibitor NSC697923 reduced di-
ubiquitin formation in a concentration-dependent manner, showing that K63-linked ubiquitin
chain formation is dependent upon UBC2 catalytic activity (Fig 5D). That NSC697923 was
likely to inhibit UBC2 was rationalised based on the fact that all 4 of the residues that were
mutated to make UBE2N resistant to NSC697923 are also found in UBC2 [50]. Complete inhi-
bition of di-ubiquitin formation was not achieved, perhaps due to an insufficiently long incu-
bation time for UBC2 with NSC697923. These experiments demonstrate that UBC2 and
UEV1 can form free K63-linked ubiquitin chains in vitro (Fig 5E).
The crystal structure of S. cerevisiaeMms2-Ubc13 covalently linked to a donor ubiquitin
molecule revealed the structural basis of K63 linkage specificity in ubiquitin chain formation.
In this structure, Mms2 directs the K63 residue of a putative acceptor ubiquitin into the Ubc13
active site, where it can attack Gly76 of the donor ubiquitin bound to the Ubc13 active site cys-
teine to form an isopeptide bond [51]. An overlay of this structure (PDB ID: 2GMI) with
chains A and B of our UBC2-UEV1 structure allowed the positions of the donor and acceptor
ubiquitins to be revealed in the context of the L.mexicana complex (S3C Fig). This produces a
plausible model of the quaternary complex without significant steric clashes and suggests that
the same strategy is used to confer Lys63-linkage specificity in L.mexicana and S. cerevisiae. In
support of this, two Mms2 residues shown to be required for acceptor ubiquitin binding in the
S. cerevisiaeMms2-Ubc13-Ub structure, Ser27 and Thr44, are conserved in L.mexicanaUEV1
(Ser28 and Thr45).
UBC2 can cooperate with human E3s to allow polyubiquitination in vitro
As the cognate E3s for UBC2 and UEV1 have not yet been identified, human E3s known to
catalyse ubiquitination in coordination with UBE2N were tested for their ability to similarly
cooperate with UBC2 and/or UEV1. The reasons for doing this were threefold. Firstly, to
investigate whether UBC2 could carry out the typical E2 role of facilitating ubiquitin transfer
to substrates via E3 enzymes. Secondly, in the hope of making inferences about L.mexicana
E3s that could be part of the UBC2 ubiquitination cascade and, lastly, to explore the conserva-
tion of E2-E3 interactions between L.mexicana and humans. For this purpose, two RING E3
ligases, BIRC2 and RNF8, were selected for testing on the basis that they are known to interact
with human UBE2N [52–54]. In humans, BIRC2 has wide-ranging roles including in regulat-
ing apoptosis and cell proliferation [52, 55] and RNF8 has well-characterised roles in DNA
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damage signalling [56–58]. HUWE1, a HECT E3 ligase that is not known or predicted to inter-
act with UBE2N, was also chosen for comparison [59]. All recombinant E3s used were GST-
tagged and, with the exception of HUWE1 which was N-terminally truncated, full-length.
Fig 6 shows the ubiquitination profiles observed for BIRC2, RNF8 or HUWE1 incubated
with different combinations of UBC2 and UEV1 in reactions containing UBA1a, ubiquitin
and ATP. When BIRC2 or RNF8 were incubated with UBC2 in the absence of UEV1, a promi-
nent pattern of polyubiquitination was seen (upper panel). Based on the K63-linked ubiquitin
and GST blots (middle and lower panels respectively), the polyubiquitination observed was
not K63-linked and occurred both as a result of E3 auto-ubiquitination and of free chain for-
mation and/or ubiquitination of other proteins (such as UBA1a, UBC2 or UEV1) in solution.
When BIRC2 or RNF8 were incubated with UEV1 in the absence of UBC2, polyubiquitination
did not occur. However, a single protein was present in the ubiquitin conjugate blot at around
Fig 6. Cooperation of UBC2 with human E3s in in vitro polyubiquitination. AUBA1a, ubiquitin and ATP were incubated with UBC2, UEV1 and human E3s
(BIRC2, RNF8 and HUWE1) as indicated in ubiquitination assay buffer for 1 h at 30˚C. Reactions were visualised by immunoblotting with either ubiquitin
conjugate, K63-linked ubiquitin or GST antibodies as shown. 2, UBC2; V1, UEV1; -, no UBC2 or UEV1; no E3, no BIRC2, RNF8 or HUWE1. B Schematic
summarising the findings of A. UBA1a activates ubiquitin in an ATP-dependent manner, allowing ubiquitin to bind to the active site of UBA1a via a thioester
linkage. Ubiquitin is then transferred to UBC2 which can, by interacting with the human E3s BIRC2 and RNF8, form non-K63-linked polyubiquitin chains. UEV1
inhibits this association, presumably via its interaction with UBC2.
https://doi.org/10.1371/journal.ppat.1008784.g006
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130 kDa, likely representing ubiquitinated UBA1a (as observed in Fig 5B–5D). Similarly, poly-
ubiquitination was not observed when BIRC2 or RNF8 were incubated with both UBC2 and
UEV1. In these samples, however, di-ubiquitin formation was notably increased, suggesting
that UEV1 is able to regulate UBC2 such that it switches its activity between facilitating polyu-
biquitination by E3s and forming K63-linked ubiquitin chains in complex with UEV1 (Fig
6B). In contrast, polyubiquitination was observed when either UBC2, UEV1 or UBC2 and
UEV1 were combined with HUWE1, suggesting that physical interaction between E2s and
HUWE1 may be required for HUWE1 activity. Alternatively, the truncated nature of the
recombinant HUWE1 protein, which lacks its UBA andWWE protein-protein interaction
domains, may have encouraged non-specific interaction with and ubiquitin transfer from
UBA1a. No ubiquitin conjugates were observed in the absence of both UBC2 and UEV1.
High functional conservation of human and Leishmania enzymes
In order to further interrogate the functional conservation between Leishmania and human
enzymes, the ability of UBC2 to extend ubiquitin chains on the human U-box E3 ligase CHIP
was investigated. In vitromonoubiquitination of CHIP by UBE2W can be followed by the
extension of ubiquitin chains by UBE2N-UBE2V1 and provides an example of a pair of coop-
erating E2s with distinct chain initiation and elongation functions [60–62]. To simplify the
experimental setup and interpretation of results, it was decided to select a single E1 enzyme to
facilitate ubiquitin transfer to both human UBE2W and L.mexicanaUBC2. In a thioester
assay, L.mexicanaUBA1a was shown to be equally competent at transferring ubiquitin to
UBE2W as human UBA1 (Fig 7A) and was therefore selected for use in subsequent experi-
ments. In addition to the reducible UBE2W-Ub thioester bands observed, an additional, non-
reducible band was observed following incubation of E1 and E2 enzymes. This is likely to be
N-terminally ubiquitinated UBE2W [63, 64].
When L.mexicanaUBC2 and UEV1 were incubated with human UBE2W and CHIP in the
presence of E1, ubiquitin and ATP, polyubiquitinated CHIP was observed (Fig 7B). When
UBE2W was absent from this reaction, no CHIP ubiquitination or free chain formation was
seen. Alternatively, when UBC2 and UEV1 were absent, only monoubiquitinated CHIP was
observed, suggesting that UBE2W is priming CHIP with a single ubiquitin modification that
can then be extended by UBC2 and UEV1 (Fig 7C). In this respect, UBC2 and UEV1 behave
in a similar manner to human UBE2N-UBE2V1 [60]. The absence of free chain formation in
the presence of UBC2, UEV1 and CHIP, however, is in contrast to what was reported for
human UBE2N-UBE2V1 and CHIP [60, 61]. In reactions where UBE2W was present but
CHIP was absent, a strong band at around 34 kDa was observed, likely corresponding to N-
terminally ubiquitinated UBE2W as in Fig 7A [63, 64].
Discussion
Trypanosomatids are amongst the most ancient of eukaryotes and possess some highly diver-
gent biochemistry, for example compartmentalisation of the glycolytic pathway or mRNA
trans-splicing [65, 66]. Despite this, our bioinformatic analysis of the L.mexicana genome
revealed numerous ubiquitin conjugation system components: 2 ubiquitin E1, 13 ubiquitin E2
and 79 E3 ligase genes, including 12 HECT E3s, 1 RBR E3, 5 U-box RING E3s, 57 RING and 4
RING-CH-type E3s. These numbers are similar to those of another single-celled eukaryote, S.
cerevisiae, which has 1 E1, 11 E2s and 60–100 E3s, of which 5 are HECT E3s, 2 are RBR E3s, 2
are U-box E3s, one is a RING CH-type E3 and the rest are RING E3s [67, 68]. In contrast,
humans have 2 E1s, 40 E2s and over 600 E3s, of which 28 are HECT E3s, around 15 are RBR
E3s, 9 are U-box E3s, 11 are RING CH-type E3s and the rest are RING E3s [68–72]. We also
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identified a putative SUMO E1 catalytic subunit (UBA2), a Nedd8 E1 catalytic subunit
(UBA3), a SUMO E2 (UBC9) and a Nedd8 E2 (UBC12), although E1, E2 and E3 genes for
Ubls were not extensively searched for. Despite this, previous characterisation of the T. brucei
orthologues of UBA2 and UBC9 by in vitro SUMOylation assays and UBA3 and UBC12 by
affinity purification of Nedd8 lend further weight to their proposed functions [22, 24]. Of the
putative ubiquitin E2s identified, 5 were missing the conserved asparagine residue thought to
be important for E2 catalysis [31–33]. UEV1, which also lacks the catalytic cysteine residue, is
part of the non-catalytic ubiquitin E2 variant protein family. For UBC3, UBC6, UBC11 and
UBC14, in contrast, the missing asparagine residue may indicate non-canonical methods of E2
catalysis.
Previous work has underscored the importance of the ubiquitination system in Leishmania
by demonstrating both the essentiality of the parasite proteasome and a key role for DUBs in
the life cycle of this parasite [8, 15, 16]. Our generation of a select ubiquitination gene null
mutant library revealed that 1 out of 2 ubiquitin E1s and 4 out of 13 ubiquitin E2s could not be
deleted and therefore may be essential in promastigotes. A smaller proportion (4 out of 20)
Fig 7. Ubiquitin chain extension activity of UBC2-UEV1. A Thioester assay showing ubiquitin transfer to UBE2W from both human UBA1 and L.mexicana
UBA1a. UBE2W, ubiquitin and ATP were incubated with human UBA1 or L.mexicanaUBA1a as indicated in ubiquitination assay buffer for up to 10 min at
room temperature. Samples were treated with either reducing or non-reducing sample buffer and visualised by SDS-PAGE with InstantBlue stain. BUBA1a,
ubiquitin and ATP were incubated with UBC2, UEV1, human UBE2W and human CHIP as indicated in ubiquitination assay buffer for 1 h at 30˚C. Reactions
were visualised by immunoblotting with either ubiquitin conjugate or CHIP antibodies as shown. C Schematic summarising A-B. UBA1a activates ubiquitin in
an ATP-dependent manner, allowing ubiquitin to bind to the active site of UBA1a via a thioester linkage. Ubiquitin is then transferred to HsUBE2Wwhich
monoubiquitinates HsCHIP. Alternatively, HsUBE2W can ubiquitinate its own N-terminus. Once primed with monoubiquitin, UBC2-UEV1 can extend
ubiquitin chains on HsCHIP. Lm, Leishmania mexicana; Hs,Homo sapiens. Where species is not indicated, proteins are from L.mexicana.
https://doi.org/10.1371/journal.ppat.1008784.g007
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cysteine peptidase DUBs were shown to be essential in promastigotes, perhaps due to a greater
degree of redundancy in DUB function [8]. UBC12, a putative Nedd8 E2, also appears to be
essential in promastigotes, suggesting it functions independently of the Nedd8 E1 UBA3,
which is non-essential in promastigotes. This could be due to the presence of an additional
Nedd8 E1 or a Neddylation-independent function of UBC12. In contrast, none of the HECT
or RBR E3 ligases were essential in promastigotes, likely attributable to the considerable func-
tional redundancy that characterises E3 ligases [73].
When interpreting our bar-seq data, we reasoned that since null mutants were more likely
to exhibit decreases in proportional representation as the experiments progressed, our analysis
should be limited to the identification of loss-of-fitness phenotypes. This is because decreases
in the relative abundance of a subset of null mutant lines in the population would lead to an
increase in the proportional representation of the remaining null mutant lines, potentially
mimicking gain-of-fitness phenotypes. Despite this limitation, the bar-seq approach allowed
us to identify numerous fitness phenotypes associated with the promastigote and amastigote
life cycle stages. In particular, loss-of-fitness was identified for more than one interval between
promastigote time points for Δubc9, hinting at a role for SUMOylation (UBC9), and Δhect2
and Δhect12, for HECT E3-mediated ubiquitination, in promastigote growth and/or survival.
These genes were not absolutely required for survival, however, given our ability to detect
Δubc9, Δhect2 and Δhect12 in the metacyclic promastigote samples. Also of interest was the
high degree of correlation between the data from the axenic amastigote, macrophage and
mouse infection experiments, supporting previous findings that only small transcriptomic dif-
ferences exist between axenic and intracellular amastigotes [3]. The strong phenotypes
observed for Δubc1/cdc34, Δubc2, Δuev1 and Δhect2 in the amastigote stages suggest an impor-
tant role for these genes in the successful transformation from promastigote to amastigote.
Since Δhect2 also showed loss-of-fitness in the promastigote stage, the effect of HECT2 dele-
tion on cell survival/proliferation may be a more general one. For example, if the function of
human UBE3C is shared with HECT2, then the build-up of harmful, incompletely-degraded
proteasome substrates during the differentiation process could explain the requirement for
HECT2 in amastigotes and the more subtle effect of HECT2 deletion on promastigotes [36].
Notably, the observed requirement for UBC1/CDC34 during L.mexicanamouse infection
mirrors the finding that TbCDC34 is required for infection of mice with bloodstream form T.
brucei [28]. Additionally, the human orthologues of both UBC2 and UEV1 (UBE2N and
UBE2V1 respectively) have been implicated in the differentiation of various human cell types,
perhaps pointing to a general role for these protein families in differentiation processes [30,
74–76]. Since both ubiquitination and deubiquitination enzymes have been found to be essen-
tial in the promastigote to amastigote transition, interplay between the activities of E2/E3s
(UBC1/CDC34, UBC2, UEV1 and HECT2) and DUBs (DUB4, DUB7 and DUB13) could be
crucial for maintaining an optimal abundance and/or state of modification of protein targets
that are required for differentiation. Δuba1b, Δubc14, Δhect7 and Δhect11 were lost at later
stages and Δubc9 showed cumulative loss throughout the experiments, suggesting that the
deleted genes are required for normal amastigote proliferation, including during mouse
infection.
Our finding that UBC2 and UEV1 are highly conserved at both the sequence and structural
level suggests that their function may be shared between distantly related species. For example,
that UEV1 is more similar in sequence to HsUBE2V2 and ScMMS2 than to HsUBE2V1 hints
at a possible function in DNA damage repair [40]. Our observation that UBC2 and UEV1
form a heterodimer was not unexpected and is consistent with the similar phenotypes
observed for Δubc2 and Δuev1 in promastigote to amastigote differentiation. We also found
that UBC2 is a monomer in vitro. This property is similar to HsUBE2N but contrasts with
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ScUbc13, which is a homodimer in vitro [45]. Given that dimerisation does not affect ubiquitin
transfer by another human E2, UBE2W, this difference may not be physiologically relevant
[77]. Our X-ray crystal structure of the UBC2-UEV1 heterodimer revealed high conservation
of the UBC2 active site and UBC2-UEV1 interface, highlighting the importance of stable
UBC2-UEV1 interaction in the function of this complex across diverse eukaryotes.
Subsequent biochemical characterisation of UBC2 and UEV1 revealed that UBA1a and
UBC2 are a functional ubiquitin E1-E2 pair. This demonstrates a level of specificity for E1-E2
interactions in L.mexicana, despite both UBA1a and UBA1b being more closely related to
HsUBA1 than HsUBA6. That UBA1a and UBA1b appear to have unique functions is interest-
ing since there is no obvious requirement for two ubiquitin E1s in other single-celled eukary-
otes. S. cerevisiae, for example, has only one ubiquitin E1. A differential requirement for
UBA1a and UBA1b is further supported by the likelihood that UBA1a, but not UBA1b, is an
essential gene in promastigotes.
The UBC2-UEV1 heterodimer, like its S. cerevisiae and human orthologues, is able to form
K63-linked ubiquitin chains in vitro, suggesting a role for non-degradative ubiquitin modifica-
tions in Leishmania differentiation [31, 40, 45, 46, 49]. Most of the chains observed in our in
vitro assays were di-ubiquitin, supporting our suggestion that UEV1 is more similar to human
UBE2V2, which forms di-ubiquitin in vitro, than UEV-1A (isoform 2 of UBE2V1), which
forms polyubiquitin chains [40]. Furthermore, our structural modelling of UBC2-UEV1 in
complex with donor and acceptor ubiquitins, together with the conservation of key UEV1 resi-
dues that are required for acceptor ubiquitin interaction, are consistent with a role for UEV1
in dictating K63-linked chain specificity by correctly orienting the acceptor ubiquitin [51]. In
contrast, the donor ubiquitin is thought to exhibit flexible positioning around the covalent
Cys85 linkage [51, 78]. The physiological role of ubiquitin chains generated by Leishmania
UBC2-UEV1 is currently unknown and an important area for further investigation. However,
previous research has shown that free ubiquitin chains are present in both S. cerevisiae and
human cells and that their levels (in S. cerevisiae) increase following heat shock, DNA damage
or oxidative stress [79]. Furthermore, unanchored K63-linked chains generated by the human
E3 ligases TRAF6 and TRIM32 have been shown to interact with and activate protein kinases
[80, 81] and unanchored K48-linked chains can inhibit the proteasome [82], demonstrating
that free ubiquitin chains can perform regulatory functions. Curiously, S. cerevisiaeHUL5, the
E3 ligase partly responsible for free chain formation upon stress induction [79], is related to L.
mexicanaHECT2 (45% query cover, 32.6% identity, E value: 5e-47). This raises the possibility
that HECT2 is involved in the response to environmental stresses that trigger the promastigote
to amastigote transition and may explain the requirement for HECT2 in amastigotes. Explor-
ing the potential interaction between UBC2-UEV1 or HECT2 and protein kinases involved in
stress responses is an interesting avenue for further study. Additionally, the identification of
UBC2 and UEV1 in an interactome of L.mexicanaDUB2, which is able to cleave K63-linked
diubiquitin in vitro, suggests a possible interplay between these proteins in the regulation of
K63-linked ubiquitin chains [8].
For our in vitro experiments, human BIRC2 and RNF8 provided useful tools for examining
the activity of UBC2 in the absence of available Leishmania E3s. Both BIRC2 and RNF8 were
able to form polyubiquitin chains (non-K63-linked) in a UBC2-dependent manner. Intrigu-
ingly, UEV1 effectively inhibited this reaction by switching UBC2 activity towards unanchored
K63-linked di-ubiquitin formation. This ability of UEV1 could allow UBC2 to flip between
direct (covalent attachment of ubiquitin to substrates) and indirect (unanchored ubiquitin
chain binding to regulated proteins) mechanisms of regulating other proteins as well as
between sets of protein targets, depending on the availability of UEV1. The proposed role for
UEV1 in specifying K63-linked chain formation is further supported by the observation that
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polyubiquitin chains produced in the presence of UBC2 and BIRC2 or RNF8 are not
K63-linked. In support of our finding that UBC2 acts alone with RNF8, human UBE2V1 and
UBE2V2 have been shown to be dispensable for the function of UBE2N and RNF8 in DNA
damage signalling [83]. Conversely, the formation of polyubiquitin chains on human CHIP
was seen in the presence of both UBC2 and UEV1. In this example, K63-linked ubiquitin
chains could be formed in a RING-dependent manner similar to that described for rat RNF4,
where, due to interactions between the RING domain and UBE2N/UBC2, the donor ubiquitin
is held in a ‘folded-back’ conformation poised for nucleophilic attack by K63 of the acceptor
ubiquitin bound to UBE2V2/UEV1 [78]. The ability of UBC2-UEV1 to extend ubiquitin
chains on CHIP illustrates the potential for UBC2-UEV1 to act in coordination with other E2s
in L.mexicana, although an E2 with such a role has yet to be identified.
Previous studies have investigated the importance of DUBs and the parasite proteasome at
various stages of the Leishmania life cycle [8, 15, 16]. Supplementing this, our study explores
the requirement for selected E1, E2 and E3 enzymes across the life cycle of Leishmania. Our
detailed investigation of UBC2 and UEV1, identified as essential in amastigotes, demonstrates
high levels of conservation at both the structural and functional level. Consequently, our find-
ing that the nature of UBC2 activity can be regulated by UEV1 has implications for ortholo-
gous proteins in other species.
Materials andmethods
Bioinformatic identification of ubiquitination genes
E1 ubiquitin-activating enzyme, E2 ubiquitin-conjugating enzyme and E3 ligase genes were
identified in the L.mexicana genome by performing Interpro and PFAM domain searches in
TriTrypDB (https://tritrypdb.org/tritrypdb/). The following Interpro and PFAM identification
codes were used: IPR018075, PF10585, IPR019572, IPR028077, IPR000608, IPR000569,
PF00632, IPR002867, PF01485, IPR001841, IPR011016, IPR003613 and PF04564. UniProt
(https://www.uniprot.org/) was also used to search for genes annotated with the terms
“HECT” or “RBR”. Protein BLAST searches were used to determine the percentage query
cover, percentage identity and E value for two gene sequences.
Leishmania culture
L.mexicana (MNYC/BZ/62/M379) promastigotes were grown in HOMEM (Gibco) supple-
mented with 10% v/v heat-inactivated Fetal Bovine Serum (FBS) (Gibco) and 1% v/v Penicil-
lin/Streptomycin (Sigma-Aldrich) at 25˚C. Typically, cells were split around twice a week.
Selection drugs were added to the medium as appropriate: 10 μg mL-1 blasticidin (InvivoGen),
40 μg mL-1 puromycin (InvivoGen), 10–15 μg mL-1 G418 (InvivoGen), 50 μg mL-1 hygromy-
cin (InvivoGen) and 50 μg mL-1 nourseothricin (Jena Bioscience).
Null mutant library generation
Null mutants were generated using the CRISPR-Cas9-based approach as previously described
[8, 34]. Primer sequences to allow amplification of the single guide DNAs (sgDNAs) and repair
cassettes for gene deletion were designed by entering the relevant gene identifiers into an auto-
mated web tool (http://www.leishgedit.net/Home.html). Primers for amplification of the
repair cassettes contained primer binding sites for pTBlast_v1, pTPuro_v1 or pTNeo_v1 plas-
mids (sequences available from leishgedit.net) and 30 nt homology arms to allow recombina-
tion [84]. Additionally, a T7 polymerase promoter sequence, 10 nt linker and 12 nt unique
barcode were inserted into the 5’ end of the upstream forward primer in the following order:
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5’-TAATACGACTCACTATAAAACTGGAAGXXXXXXXXXXXX-3’, where X represents the
barcoded region.
PCR reactions for cassette amplification contained 30 ng of plasmid (pTBlast_v1,
pTPuro_v1 or pTNeo_v1), 0.2 mM dNTPs, 2 μM each of forward and reverse primer, 1U Q5
DNA Polymerase (NEB), 1x Q5 reaction buffer (NEB) and distilled water to make the volume
up to 40 μL. The reverse primer used for generating all guides was aaaagcaccgactcggtgccacttttt-
caagttgataacggactagccttattttaacttgctatttctagctctaaaac. The PCR was run with the following set-
tings: 94˚C for 5 min, 45 cycles of 94˚C for 30 s, 65˚C for 30 s and 72˚C for 2 min 15 s and
72˚C for 7 min. For the sgRNAs, PCR reactions were set up in a similar manner but with a
total volume of 20 μL. The PCR program used was 98˚C for 30 s, 35 cycles of 98˚C for 10 s,
60˚C for 30 s and 72˚C for 15 s and 72˚C for 10 min.
Mid-log phase L.mexicana Cas9 T7 procyclic promastigotes were transfected either with
whole PCR reactions (120 μL total volume) or 2.5 μg of DNA purified from PCR reactions using
the QIAquick PCR Purification Kit (Qiagen). 8 x 106 log phase cells were prepared by spinning
down (1,000 x g for 10 min), washing with 1 x PBS and resuspending in 1 x Cytomix (66.7 mM
Na2HPO4, 23.3 mMNaH2PO4, 5 mMKCl, 50 mMHEPES and 150 μMCaCl2, pH 7.3) or P3
solution from the P3 Primary Cell 4D-Nucleofector X Kit (Lonza). Next, cells were pulsed twice
using the Nucleofector 2B device (Lonza) and the X-001 program or using the Amaxa 4D-Nucleo-
fector (Lonza) and the FI-115 programme (for the Cytomix and P3 solutions respectively) and
then placed into 5 mL of HOMEMmedia with 20% FBS and 1% Penicillin/Streptomycin. As a
negative control, the parental cell line was transfected with water in place of DNA.
Following recovery of the cells at 25˚C, appropriate antibiotics were added (10 μg mL-1
blasticidin, 40 μg mL-1 puromycin, 15 μg mL-1 G418) to select for transfectants. Selection was
performed either on a population level (10 mL containing the total transfected population) or
along with cloning into 96-well plates at 1:6, 1:66 and 1:726 dilutions. Dilutions were carried
out in HOMEM supplemented with 20% v/v FBS and 1% v/v Penicillin/Streptomycin.
To extract genomic DNA for analysis, 500 μL-5 mL of mid-log phase promastigotes were
centrifuged (1,000 x g for 10 min), washed once in 1 x PBS and processed using the Qiagen
DNeasy Blood and Tissue Kit and the manufacturer’s protocol. For genotype analysis, PCR
reactions were set up with 1 μL of genomic DNA and either Q5 DNA Polymerase (NEB) or
LongAmp Taq (NEB) with the manufacturer’s protocols.
Bar-seq screen
The bar-seq screen was performed as described previously in Damianou et al., 2020 [8]; the
raw data are available in S4 Table. Statistical analyses were performed between adjacent experi-
mental time points using paired t-tests and the Holm-Šı́dák method in GraphPad Prism 8.
Cell viability assay
L.mexicana cultures were grown to stationary phase (>1 x 107 mL-1) and resuspended at 1 x
106 cells per mL in amastigote medium (Schneider’s Drosophila medium [Gibco], 20% FBS
[Gibco] and 15 μg mL-1 HEMIN [Sigma], adjusted to pH 5.5). 200 μL cell samples were pre-
pared in sextuplicate in 96-well plates and included the parental cell line (Cas9 T7) as a positive
control. Also included were media-only, negative control samples. At 0 h, 48 h and 120 h,
20 μL of 125 μgmL-1 resazurin (in 1 x PBS) was added to sample wells and the plate incubated
at 37˚C for 8 h. The fluorescence at 590 nm was then read using the POLARstar Omega Plate
Reader (BMG Labtech). Relative viability was calculated for each sample by averaging fluores-
cence readings across the 6 replicates, subtracting the average for the negative control and then
dividing by the value obtained for the Cas9 T7 positive control.
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Sequence alignments
S. cerevisiae sequences were obtained from UniProtKB [85], human sequences from Uni-
ProtKB or NCBI and L.mexicana and T. brucei sequences from TriTrypDB [86]. Sequence
alignments were performed using T-Coffee [87] and structural annotation using ESPript 3.0
[88].
Protein expression and purification
UBA1a (LmxM.23.0550), UBC2 (LmxM.04.0680) and UEV1 (LmxM.13.1580) genes were
codon-optimised for E. coli expression and synthesised by DC Biosciences. Genes were ampli-
fied by PCR and inserted into an expression vector (Protein Production Facility, University of
York) in frame with an N-terminal His tag and Im9 solubility tag [41] using In-Fusion cloning
(Takara). Primers used for gene amplification were 5’-TCCAGGGACCAGCAATGCTTTCT
GAGGAAGAGCAAAAAC-3’ and 5’-TGAGGAGAAGGCGCGTTAAAAGCGATAGCGGT
AGCGGATG-3’ for UBA1a, 5’-TCCAGGGACCAGCAATGTTGACCACTCGTATCATTAA
GG-3’ and TGAGGAGAAGGCGCGTCATGGTTTGGCGTACTTACGAG-3’ for UBC2 and
5’-TCCAGGGACCAGCAATGGTCGAGGTTCCGCGC-3’ and 5’-TGAGGAGAAGGCGCG
TCAGTAGGTACTACCCTCC-3’ for UEV1. Insert integration and sequence were confirmed
by DNA sequencing (Eurofins). Plasmids were then transformed into BL21-Gold (DE3) cells
(Agilent Technologies). Cells were grown overnight in 5 mL of LB medium with 25 μgmL-1
kanamycin and used to seed 500 mL cultures for growth at 37˚C. When an optical density of
around 0.5 at 600 nm was reached, cultures were equilibrated to 20˚C and 1 mM of isopropyl
1-thio-β-D-galactopyranoside was added to induce recombinant protein production. Cultures
were then grown for a further 24 h at 20˚C.
The standard purification procedure was as follows: bacterial pellets from 500 mL cultures
were resuspended in 25 mL buffer A (20 mMNaH2PO4�2H2O, 20 mMNa2HPO4�12H2O, 0.3
M NaCl, 30 mM imidazole and 5 mM β-mercaptoethanol, pH 7.4), DNase-treated and homog-
enised using a cell disruptor (Constant Systems Ltd). The lysate was centrifuged (35,000 x g, 10
min, 4˚C), filtered and loaded onto a HisTrap Fast Flow Crude column (GE Healthcare). After
column washes with buffer A, a gradient of buffer B (20 mMNaH2PO4�2H2O, 20 mMNa2H-
PO4�12H2O, 0.3 M NaCl, 0.5 M imidazole and 5 mM β-mercaptoethanol, pH 7.4) was applied
to elute bound protein. His-Im9 tag cleavage was then carried out using at least one tenth
HRV 3C protease (Protein Production Facility, University of York) to sample protein (mg).
This was followed by imidazole removal using either overnight dialysis at 4˚C in buffer C (20
mMNaH2PO4�2H2O, 20 mMNa2HPO4�12H2O, 0.3 M NaCl and 5 mM β-mercaptoethanol,
pH 7.4) or a desalt column. Removal of the His-Im9 tag leaves an additional 3 amino acids
(Gly, Pro, Ala) at the N-terminus. Following cleavage, the sample was reapplied to the HisTrap
column and application of buffer A and B used to separate the tag from the protein of interest.
Sample fractions were concentrated and size-exclusion chromatography (SEC) carried out
using HiLoad 16/600 Superdex 200 preparation grade (pg) or 75 pg columns (GE Healthcare)
for UBA1a and UBC2 or UEV1 respectively. Buffer used for SEC contained 50 mMHEPES
and 150 mMNaCl with either 2 mMDTT (UBC2 and UEV1) or 1 mM TCEP (UBA1a). Frac-
tions containing purified protein were identified by SDS-PAGE analysis, pooled, concentrated
and stored at -80˚C.
For the UBC2 and UEV1 samples used for SEC-MALLS, purification was carried out
as described above but with the following minor changes: buffers A-C did not contain
β-mercaptoethanol, UBC2 was not purified by SEC and the buffer used for SEC of UEV1 was
25 mM Tris-HCl, 150 mMNaCl, pH 8. Storage was in the final purification buffers plus 1 mM
DTT.
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Size-exclusion chromatography multi-angle laser light scattering
(SEC-MALLS)
Prior to loading, mixtures of UBC2 and UEV1 were prepared as required and incubated on ice
for 30 min. 120 μL of each sample was then loaded onto a Superdex 200 HR10/300 gel filtration
column (Sigma-Aldrich) and run in 25 mM Tris-HCl, 150 mMNaCl and 1 mMDTT, pH 8.
Light scattering and refractive index measurements were taken using a Dawn Heleos II and
Optilab rEx detector (Wyatt) respectively. Concentrations of samples loaded were between 1.2
and 2 mg mL-1.
Crystallisation and structure determination
For crystallisation experiments, UBC2 and UEV1 were mixed in a 1:1 molar ratio to a final
concentration of 6.6 mg mL-1 in buffer containing 50 mMHEPES, 150 mMNaCl and 2 mM
DTT and incubated on ice for 30 min. Crystallisation conditions were screened (PACT pre-
mier HT-96 screen, Molecular Diagnostics) in a 96-well sitting drop format. Drops consisting
of 150 nL of protein and 150 nL of reservoir solution were mixed and incubated above 100 μL
of reservoir solution. Crystals appeared after two days at 25˚C in drops prepared with a reser-
voir solution consisting of 0.1 M Bis-Tris propane, pH 7.5, 0.2 M sodium formate and 20%
PEG. A single crystal was captured in a fine nylon loop, cryo-cooled in liquid nitrogen, and
sent for data collection at the Diamond Light Source (Beamline I03). The diffraction data,
extending to a nominal resolution of 1.7 Å, were processed using the 3dii pipeline in xia2 [89].
The crystals belonged to space group P21 with two UBC2-UEV1 heterodimers in the asymmet-
ric unit.
The structure was solved by molecular replacement in the programMOLREP [90] imple-
mented in the CCP4i2 interface [91]. The search model used was the coordinate set for the
human UBE2N-UBE2V2 complex (PDB ID: 1J7D). Model rebuilding and refinement were
carried out using iterations of the programs Buccaneer [92] Refmac5 [93, 94] and Coot [95] in
CCP4i2 [91]. The electron density maps were of good quality allowing the confident tracing of
the protein chains in the two heterodimers (AB and CD) with the exception of residues in the
α1-β1 loop of UEV1 chains (B and D) where the maps were of poorer quality such that resi-
dues Gly22 and Ser23 could not be built in Chain D. It is assumed that this region of the struc-
ture has higher mobility. Data collection and refinement statistics are given in S4 Table. The
coordinates and structure factors for the L.mexicanaUBC2-UEV1 complex are available in
the Protein Data Bank (PDB ID:6ZM3).
Structure analysis
Superposition of structures and RMSD determination were performed using “superpose struc-
tures” in CCP4mg [96]. UBC2-UEV1 interface analysis was performed using PISA (version
1.52) [97].
Thioester formation assay
Reactions contained 300 nM UBA1a, 2.5 μME2, 20 μM human ubiquitin (Boston Biochem)
and 5 mM ATP as indicated in 40 μL ubiquitination assay buffer (50 mMHEPES, pH 7.5, 100
mMNaCl, 10 mMMgCl2 and 2 mMDTT). Reactions were incubated for 0–10 min at room
temperature and then quenched with sample buffer with or without reducing agent. Samples
containing reducing agent were heated at 90˚C for 5 min. Samples were run on an SDS-PAGE
gel and stained with InstantBlue Coomassie Protein Stain (Expedeon). For the UBE2W thioe-
ster assay, bovine ubiquitin (Ubiquigent) was used in place of human ubiquitin. For the
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thioester assay with UBA1b (donated by Daniel Harris, University of Glasgow), the protocol
differed slightly in that 100 μM human ubiquitin and 10 mM ATP were used and the reactions
were incubated at 30˚C for 30 min.
Di-ubiquitin formation assay
Reactions contained 100 nM UBA1a, 2.5 μM of UBC2 and UEV1, 100 μM of human wild-type
(Boston Biochem) or K63R ubiquitin (2B Scientific) and 5 mM ATP as indicated in 40 μL of
ubiquitination assay buffer. Samples were incubated at 37˚C for between 0 and 90 min as indi-
cated. For the inhibitor assay, 0–50 μM of NSC697923 (Abcam) was pre-incubated with UBC2
and UEV1 in reaction buffer for 15 min at room temperature prior to addition of UBA1a and
ATP. The reaction was then incubated at 37˚C for 90 min. The final DMSO concentration in
these reactions was 0.5%. Following incubation, reducing sample buffer was added and the
samples heated at 90˚C for 5 min. Samples were separated by SDS-PAGE andWestern blotting
carried out using a mouse mono- and polyubiquitinated ubiquitin conjugate (Ubiquigent) or
mouse Ub-K63 (ThermoFisher) antibody with HRP-conjugated anti-mouse secondary anti-
body (GE Healthcare or Promega). In addition to the experimental samples, 100 ng of K63 di-
ubiquitin positive control (Ubiquigent) was loaded where indicated.
E3 cooperation assay
Reactions were prepared with 100 nM UBA1a, 2.5 μME2 (UBC2 or UEV1), 1 μM human E3
(BIRC2, RNF8 or HUWE1), 100 μM ubiquitin (Boston Biochem) and 5 mM ATP as indicated
in ubiquitination assay buffer in 40 μL total reaction volume. BIRC2, RNF8 and (N-terminally
truncated) HUWE1 were all GST-tagged and sourced from Ubiquigent. Samples were then
incubated at 30˚C for 1 h prior to SDS-PAGE andWestern blotting with a mouse mono- and
polyubiquitinated ubiquitin conjugate (Ubiquigent), mouse Ub-K63 (ThermoFisher) or rabbit
anti-GST (Abcam) antibody with HRP-conjugated anti-mouse (GE Healthcare) or HRP-con-
jugated anti-rabbit (GE Healthcare) secondary antibody as appropriate.
CHIP priming and extension assay
Reactions were prepared with 0.1 μMUBA1a, 2.5 μM 6His-tagged UBE2W (Ubiquigent),
1 μMCHIP (Ubiquigent), 0.1 mM human ubiquitin (Boston Biochem) and 2 mM ATP
(Sigma-Aldrich) in ubiquitination assay buffer in 50 μL total reaction volume. Samples were
incubated at 30˚C for 1 h prior to SDS-PAGE andWestern blotting with a mouse mono- and
polyubiquitinated conjugate (Ubiquigent) or rabbit CHIP antibody (Calbiochem) with HRP-
conjugated anti-mouse (GE Healthcare) or HRP-conjugated anti-rabbit (GE Healthcare) sec-
ondary antibody as appropriate.
Supporting information
S1 Table. Summary of L. mexicana ubiquitination genes.
(XLSX)
S2 Table. Summary of primers and plasmids.
(XLSX)
S3 Table. Individual viability assay of Δubc1, Δubc2, Δuev1 and Δhect2 during axenic
amastigote differentiation. Raw fluorescence (590 nm) readings and relative viabilities com-
pared to the Cas9 T7 cell line are included.
(XLSX)
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S4 Table. Data collection and refinement statistics for UBC2-UEV1 crystal structure.
(XLSX)
S1 Fig. Partial alignments of L. mexicana and H. sapiens protein sequences. Sequences
obtained from TriTryDB (L.mexicana) and NCBI or UniProt (H. sapiens) were aligned using
T-Coffee. Residues in the local vicinity of the putative active site cysteine of A ubiquitin
E1-activating enzymes, B E2-conjugating enzymes and C E3 ligase HECT domains are shown.
Red boxes indicate amino acid identity, red characters show similarity within the highlighted
group and blue frames highlight similarity across groups. Black bar indicates the position of
the conserved HPNmotif in E2 genes and the black triangles highlight the conserved catalytic
cysteine residues in all classes of protein. L.mexicana genes are indicated with the prefix Lm
andH. sapiens genes with the prefix Hs. Where no prefix is given, sequences belong to L.mexi-
cana.
(TIF)
S2 Fig. Confirmation of the null mutant library. A Schematic of PCRs performed to identify
null mutants from heterozygotes or mutants with additional gene copies. Primers were
designed to amplify regions within the gene of interest (GOI, red primers) and between the 5’-
UTR of the gene and the blasticidin repair cassette of the edited DNA (black primers). B PCRs
performed on genomic DNA from parental (P) and mutant (M) cells are shown for genes that
were deleted successfully. Due to the large size ofHECT3 (18.6 kbp), only the first 8 kbp of the
gene was targeted for editing. TheHECT3 gene PCR was designed to amplify within the tar-
geted region. C PCRs performed on genomic DNA from parental (P) and mutant (M) cells are
shown for genes that could not be deleted (no mutant clones were obtained for UBC13).D
Relative viability of Δubc1, Δubc2, Δuev1 and Δhect2 compared to the parental Cas9 T7 line
during promastigote to amastigote differentiation. Time elapsed since the initiation of differ-
entiation is marked on the x-axis. Data are an average of two independent experiments, each
with 6 biological replicates.
(TIF)
S3 Fig. Structural analysis of the UBC2-UEV1 heterodimer. A Superposition of chains A
and B for UBC2-UEV1 (dark green and dark blue, PDB ID: 6ZM3), HsUBE2N-UBE2V2
(darker green and darker blue, PDB ID: 1J7D) and ScUbc13-Mms2 (light green and light blue,
PDB ID: 1JAT). Locations of the N- and C-termini are shown. B Zoom-in of the interface
between UBC2 and UEV1 showing residues thought to contribute most significantly to com-
plex formation according to analysis in the program PISA [97]. Residues are labelled in black
for UBC2 and blue for UEV1. Residues are coloured by atom (red, oxygen; blue, nitrogen).
Hydrogen bonds are denoted by dashed lines. C Superposition of UBC2-UEV1 onto the struc-
ture of the UBE2N-UBE2V2-Ub complex (PDB ID: 2GMI) [51] showing UBC2 (green) and
UEV1 (blue) as space fill models and the positions of acceptor and donor ubiquitins (orange
ribbons) obtained from the UBE2N-UBE2V2-Ub structure. C85 is represented by black (car-
bon) and yellow (sulfur) spheres. K63 of ubiquitin is highlighted as cylinders coloured by atom
(blue, nitrogen).
(TIF)
S4 Fig. UBA1b cannot transfer ubiquitin to UBC2 in vitro. A Alignment of L.mexicana and
H. sapiens ubiquitin protein sequences. Red boxes indicate amino acid identity, red characters
show similarity within the highlighted group and blue frames highlight similarity across
groups. BUBA1b and ubiquitin were incubated with UBC2, UEV1 and ATP as indicated in
ubiquitination assay buffer for 30 min at 30˚C. Samples were treated with either reducing or
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non-reducing sample buffer and visualised by SDS-PAGE with InstantBlue stain.
(TIF)
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